Drug Conjugates for Targeting Eph Receptors in Glioblastoma
Glioblastoma (GBM) is a complex and heterogeneous tumor that warrants a comprehensive therapeutic approach for treatment. Tumor-associated antigens offer an opportunity to selectively target various components of the GBM microenvironment while sparing the normal cells within the central nervous syst...
Saved in:
Main Authors: | Puja Sharma (Author), Callie Roberts (Author), Denise Herpai (Author), Izabela D. Fokt (Author), Waldemar Priebe (Author), Waldemar Debinski (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment
by: Analiz Rodriguez, et al.
Published: (2015) -
Antibody Targeting of Eph Receptors in Cancer
by: Peter W. Janes, et al.
Published: (2020) -
Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma
by: Kyeongjin Seo, et al.
Published: (2024) -
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids
by: Lorenzo Guidetti, et al.
Published: (2022) -
Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)
by: Theodore J. Kottom, et al.
Published: (2024)